EU Says Cephalon and Teva May Have Hindered Sales of their Generic Drug, EU will Probe Deal (CEPH, TEVA)

by Theo Kratz, Benzinga Staff Writer
April 28, 2011 11:03 AM | 8 seconds read |
EU says Cephalon CEPH and Teva TEVA may have hindered sales of their generic drug.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsLegalGlobalBiotechnologyHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!